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A B S T R A C T
Metabolic syndrome (MeS) is defined by a cluster of abnormalities comprising obesity, hypertension, carbohydrate in-
tolerance and dyslipidemia. MeS increases the risk of developing various diseases, including coronary heart disease,
stroke, peripheral angiopathy and type 2 diabetes1,2. In our study, the subjects were 561 persons, residents of 11 homes for
the elderly in Zagreb, Croatia. There were 160 men (28,5%) and 401 women (71.5%), aged from 56 to 96 years (the aver-
age being 79 years). Physical examination was conducted, which included blood pressure measurement, and body height
and weight. Blood samples were taken for biochemical analysis. Along with other biochemical parameters, the levels of
glucose, triglycerides and cholesterol (LDL, HDL-C) were also measured. The results have shown the prevalence of MeS
in the elderly instutionalised people to be in the range of 20.8%, according to WHO criteria. The most common MeS com-
ponent was hypertension, and it was significantly more frequent in women than in men; also, the elevated triglyceride
levels were more often found in women; the difference between men and women was also statistically significant. MeS is
a serious and growing health problem not only in Croatia but worldwide as well. Further studies are needed to verify the
prevalence of MeS in Croatia, as it is a major risk for CVD and many other severe diseases.
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Introduction
Metabolic syndrome (MeS) is defined by a cluster of
abnormalities that consists of obesity, hypertension, car-
bohydrates intolerance and dyslipidemia. MeS increases
the risk of developing various diseases, including coro-
nary heart disease, stroke, peripheral angiopathy and
the development of type 2 diabetes1,2. At first MeS was
named »syndrome X« and in 1998 the term »metabolic
syndrome« was accepted by the World Health Organiza-
tion (WHO) and according to WHO criteria obesity was
taken as the main component for the definition of MeS3.
Prevalence of MeS rises with age and it is believed that
40% of individuals of 60 years and above, and 10% in the
age group 20–60 years have MeS4,5. Significant increase
in MeS prevalence is noted in developed countries, recent
studies showed that age adjusted prevalence (adults 20
and above) of MeS in the U.S. rose from 24% in NHANES
III4 study to 27% in NHANES study6. Undeveloped coun-
tries also are not excluded, where MeS prevalence is
increased especially in the obese and the overweight
youth7. Two recent studies in isolated populations in
Croatia were conducted, one took place in the interior of
Croatia: the Baranja region; and the other in an island
population of eastern Adriatic coast, they showed the
prevalence of MeS of 40 and 42% respectively8. The data
about the prevalence of MeS in the elderly population
vary, ranging from 11.3% in women and 12.5% in men in
people over 70 in a French representative study of the
population (using NCEP ATP III criteria) and up to 69%
in a Greek population-based study (using the IDF crite-
ria). We found no data in the literature about the preva-
lence of MeS in the elderly population of Croatia9.
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There are several definitions used to identify MeS,
such as the WHO criteria, European group for the study
of insulin resistance (EGIR) criteria, National choles-
terol education program – adult treatment panel (NCEP
ATPIII) criteria and International diabetes federation
(IDF) criteria. Mostly two definitions are used in diag-
nosing MeS, the WHO criteria and the second one as de-
fined in the NCEP ATP III criteria10,11. In our survey we
used the WHO criteria that take obesity as the main
component of MeS. With obesity, as the main component,
at least two of the following four components must be
fulfilled: carbohydrate intolerance (fasting glucose above
6.1 mmol/L), elevated blood pressure (measured above
140/90 mmHg), elevated triglycerides (above 1.7 mmol/L),
low HDL – cholesterol (in men <0.9mmol/l; women <1.0
mmol/L) and obesity (waist hip ratio more than 0.9 in
men and more than 0.85 in women; or body mass index
(BMI) over 30 km/m2).
Materials and Methods
Subjects were 561 persons, residents of 11 old peoples’
homes in Zagreb, Croatia, 160 men (28.5%) and 401
women (71.5%), aged 56 to 96 (average 79 years). Physical
examination was conducted, which included measuring of
blood pressure, height and weight. Blood samples were
taken for biochemical analysis. Along with other biochem-
ical parameters we measured level of glucose, triglycerides
and cholesterol (LDL, HDL-C). 505 subjects had all the
data need for detection of MeS, and 56 subjects had miss-
ing data, invalid data or have left the study. They were ex-
cluded from further evaluation of MeS prevalence.
WHO criteria takes hyperglycemia (defined as a his-
tory of diabetes or a fasting blood glucose greater than or
equal to 6.1 mmol/L) as the main component of MeS with
at least two of the following four components:
1) hypertension – defined as a history of hypertension
or a blood pressure greater than or equal to 140/90
mm Hg
2) hypertriglyceridemia – defined as fasting triglycer-
ides greater than or equal to 1.7mmol/L
3) a low HDL-C – defined as a fasting HDL-C less
than 0.9 mmol/L in men or less than 1.0 mmol/L in
women, and
4) central obesity – defined as a Body Mass Index
(BMI) greater than or equal to 30 kg/m2
Data were collected individually, in the institution, as a
part of a greater longitudinal study named »Biological,
psychological and sociological factors of health in old age«
which also included testing of psychological and sociologi-
cal factors of ageing. The study received approval from
ethical committee. All participants have signed informed
consent and no fee was paid to participants, they could
leave the research at their own will at any time without
any consequences. Results were statistically analyzed us-
ing statistical software package Statistica 7. Level of sta-
tistical significance was set at 95% (alpha = 95%), p value
less than 0.05 was considered as statistically significant.
Results
We found positive criteria for MeS in 35 men and in 70
women, with prevalence of MeS of 25.4% in men, and
19.1% in women. Totally, MeS was noted in 120 partici-
pants with the prevalence of 20.8%. When we analyzed
the components of MeS separately, abnormal glucose
level or previous diagnosis of diabetes mellitus was found
in 35 men (25.4%) and 70 women (19.1%). Triglycerides
levels were elevated in 38 males (27.5%) and 138 females
(37.6%). HDL – cholesterol was below normal level in 18
males (13.0%) and 31 females (8.4%). Elevated BMI
(equal to or above 30 kg/m2) was noticed in 21 males
(16.4%) and 90 females (23.7%). Prevalence of metabolic
syndrome components shows that hypertension is pres-
ent in 87 men (54.4 %) and 276 women (68.8%). Totally,
elevated glucose level or previous diagnosis of diabetes
mellitus was found in 120 participants (21.3%). Abnor-
mal triglycerides levels were noticed in 206 subjects
(36.5%). Low HDL cholesterol has been established in 49
examinees (9.7%). Hypertension was recorded in 363
participants (64.7%), and elevated BMI we found in 111
subjects (21.9%). When comparing components of MeS in
men and women, we found that men had higher percent-
age of glucose intolerance or diabetes mellitus (25.4 to
20.8%) and abnormal levels of HDL cholesterol (13.0 to
9.7%), but the difference was not statistically significant
(p>0.05 and p>0.05). We also noticed that women more
often have elevated triglycerides levels (27.5 to 34.8%),
elevated blood pressure (68.8 to 54.4%) and elevated BMI
(23.7 to 16.4%). Statistical significance was found when
comparing elevated triglycerides levels and elevated
blood pressure in women and men (p=0.03 and p<0.01
respectively). There was no statistical significance for
BMI between men and women (p>0.05). All data are
summarized in Table 1.
Discussion
In our current study the criteria proposed by the
WHO for the epidemiological studies, which excluded
microalbuminuria, for the MeS were used. Our results
show that prevalence of MeS in an old people is 20.8% us-
ing the WHO criteria. MeS was found more frequently in
men than in women (25.4 to 19.1%) but the difference
was not statistically significant (p>0.05). The most fre-
quent MeS component was hypertension, and it was sig-
nificantly more frequent in women than in men (p<
0.05), also raised triglycerides levels were more often
found in women, the difference was also statistically sig-
nificant (p<0.05).
MeS is believed to be a strong predictor of cardiovas-
cular disease (CVD), which was confirmed by a number
of studies12. A sub-study of Botonia study, which included
4000 Finish and Swedish adults, showed that people with
MeS have a three times higher risk of CVD that those
without the syndrome, also cardiovascular mortality was
significantly increased (12% to 20%) in people with MeS
than in those without the syndrome 13. Mentioned above
was confirmed by the number of observational studies
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which included the Finnish Kuopio study14, the San An-
tonio Heart Study15; European DECODE Study16 and
the AIRC study17. Also some studies have disputed whe-
ther the MeS is a good predictor of CVD above individual
CVD risks, this was possibly related to an inadequate
definition of MeS or the cut points used18. When compar-
ing people who meet criteria for MeS but do not have dia-
betes, it has been noted that they have a very high risk
for developing diabetes; the risk is five times higher than
in people without MeS18. According to McNeill et al.
women and men with MeS were 20% to 30% more likely
to develop any CVD than subjects without MeS19. Many
international studies have shown high correlation of
MeS and the complex diseases, coronary disease, brain
infarction and diabetes type II20–22. When comparing our
results to similar studies we found that our results were
in concordance with their findings. Earl et al.23 showed
that the prevalence of MeS in US adults was 21.8% to
23.7%. Also they have noted that the prevalence of MeS
rises with age, from 6.7% in individuals aged 20–29 to
43.5% in subjects aged over 60, their results are some-
what higher than ours, taking in consideration that most
of our population was aged above 60. It must be noted
that they have used ATP III citeria for definition of MeS,
which is much more sensitive. We found no comprehen-
sive data for MeS prevalence in Croatia, some studies
performed in an isolated population were made. Missoni
conducted a research in the isolated population of the is-
land of Vis, he used WHO criteria for MeS definition and
the NCEP ATP III criteria for MeS definition. He found
that 21.2% of subjects have MeS using the WHO criteria,
this results are also in concordance with ours. MeS prev-
alence using the NCEP criteria was 47.2%, which proved
that NCEP criteria is more sensitive than the WHO esti-
mation. It also should be noted that hypertension was
again the most often single risk factor for MeS24. Missoni
also noted that MeS in somewhat important factor for
development of complex diseases, and also in his study
was shown that 66.7% of subjects with malignant tumors
have MeS as well, and that could suggest that MeS is also
a high risk factor for those complex diseases24. A few
other studies using the WHO criteria for MeS were con-
ducted in Croatia. Deka et al. found that the prevalence
of MeS using the BMI as the indicator of obesity is 26% in
the island of Hvar (32% in men and 24% in women above
the age of 19)1. Kolcic et al. preformed a several studies
in Croatia, in an isolated island population of Rab, Mljet,
Vis and Lastovo. The highest prevalence of MeS was
found in Mljet (using the NCEP version) of 53%2.
High prevalence of MeS was also found in Baranja re-
gion in the study of Tucak-Zoric et al., prevalence is high
as 40% (35% in males and 42% in females) with BMI as
predictor of obesityS25. Unfortunately there is no data
about the overall prevalence of MeS in Croatia, and there
is no data about MeS in the elderly population of Croatia.
B. Nevajda et al.: Metabolic Syndrome in Older People, Coll. Antropol. 37 (2013) 1: 203–206
205
TABLE 1
METABOLIC SYNDROME ACCORDING TO WHO AND GENDER
Gender c2
Male % Female % N % Value df p
Glucose
Normal 103 74.6 297 80.9 400 79.2
2.41 1Abnormal 35 25.4 70 19.1 105 20.8 0.12
N 138 100 367 100 505 100
Triglycerides
Normal 100 72.5 229 62.4 329 65.2
4.47 1Abnormal 38 27.5 138 37.6 176 34.8 0.03*
N 138 100 367 100 505 100
HDL-cholesterol
Normal 120 87.0 336 91.6 456 90.3
2.42Abnormal 18 13.0 31 8.4 49 9.7 1 0.12
N 138 100 367 100 505 100
Hypertension
Normal 73 45.6 125 31.2 198 35.3
10.46Abnormal 87 54.4 276 68.8 363 64.7 1 0.00*
N 160 100 401 100 561 100
BMI
Normal 107 83.6 290 76.3 397 78.1
2.97Abnormal 21 16.4 90 23.7 111 21.9 1 0.08
N 128 100 380 100 508 100
MS (WHO)
No 103 74.6 297 80.9 400 79.2
2.41Yes 35 25.4 70 19.1 105 20.8 1 0.12
N 138 100 367 100 505 100
p<0.05; N – number of participants; df – degrees of freedom
Conclusion
MeS is a serious and growing health problem world-
wide and in Croatia. Further studies are needed to verify
the prevalence of MeS in Croatia as it a major risk for
CVD and complex diseases. Studies are especially needed
in subjects of all ages so preventive actions, including the
education about exercise and nutritional habits, could be
performed until it is too late.
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PREVALENCIJA METABOLI^KOG SINDROMA KOD STARIJE INSTITUCIONALIZIRANE
POPULACIJE, ZAGREB, HRVATSKA
S A @ E T A K
Metaboli~ki sindrom (MeS) definiramo nizom abnormalosti, uklju~uju}i gojaznost, povi{en krvni tlak, netoleranciju
na ugljikohidrate i dislipidemiju. MeS pove}ava opasnost nastanka niza bolesti, kao npr. koronarne sr~ane bolesti,
mo`danog ili sr~anog udara, periferne angiopatije te dijabetesa tip 21,2. U na{em ispitivanju je sudjelovala 561 osoba; to
su bili {ti}enici domova za starije i nemo}ne osobe u Zagrebu, RH. Bilo je 160 mu{karaca i 401 `ena u dobi izme|u 56 i
96 godina (prosje~na dob je 79 godina). Obavljeni su fizikalni pregledi, uklju~uju}i mjerenje krvnog tlaka te tjelesne
te`ine i visine, a krv im je izva|ena radi biokemijskih analiza. Od niza biokemijskih parametara mjerena je i razina
{e}era u krvi, triglicerida i kolesterola (LDL, HDL-C). Rezultati ukazuju na metaboli~ki sindrom u 20,8% starijih insti-
tucionaliziranih osoba i to prema kriterijima Svjetske zdravstvene organizacije. Naj~e{}a komponenta MeS-a je povi{en
krvni tlak, i to vi{e u `ena nego u mu{karaca, a i povi{ena razina triglicerida je tako|er ~e{}a u `ena, uz statisti~ki
zna~ajnu razliku izme|u te dvije skupine ispitanika. MeS je zna~ajan i rastu}i zdravstveni problema ne samo u Hrvat-
skoj ve} i u cijelom svijetu. Potrebna su daljnja ispitivanja kako bi se potvrdila prevalencija MeS-a u Hrvatskoj, jer je to
zna~ajan rizi~ni ~imbenik ne samo za sr~ano`ilne bolesti ve} i za niz drugih te{kih bolesti i stanja.
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